Ed Gillis, CEO of Revolution Contraceptives, the social venture company tasked with developing Vasalgel for Parsemus Foundation, traveled to Paris this spring to exchange ideas
Vasalgel made the Daily Beast’s list of the medical advances in 2017 that “are going to not only dramatically transform how we think about the
Usually, the development of a medical device happens out of the public eye, but in our case, we have shared information with the public and
How will the availability of new male contraceptive options impact the number of unintended pregnancies? Researchers recently created a model to answer that question in
Good news for Vasalgel! Ed Gillis has joined the team as CEO of Revolution Contraceptives, LLC, the social venture company that is developing Vasalgel under
You can see an “inside view” of Vasalgel in action thanks to this video representation with animation by Filip Spasev and Will Justice. The project
Successful reversal of Vasalgel male contraceptive in rabbits For immediate release: Vasalgel’s prevention of sperm transport in the vas deferens for 14 months was reversed
Vasalgel given to 16 monkeys resulted in 100% successful contraception — no pregnancies after 1 to 2 years. The results, published in Basic and Clinical
Press Release Monday, Feb. 6, 2017 20:00 EST New contraceptive Vasalgel provides effective birth control in rhesus monkey groups for more than one year: report
Vasalgel was listed as #5 on the Cracked list of science breakthroughs that might save humanity. This revolutionary male contraceptive has the potential to change